Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58512-50-8

Post Buying Request

58512-50-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58512-50-8 Usage

Physical state

Clear, colorless liquid

Uses

a. Solvent in industrial processes
b. Intermediate in chemical synthesis
c. Additive in various applications

Primary applications

a. Production of polymers
b. Production of resins
c. Production of coatings

Potential applications

a. Synthesis of pharmaceuticals
b. Synthesis of fine chemicals

Toxicity

Low toxicity

Environmental impact

Not considered a significant environmental hazard

Safety precautions

Proper handling and storage procedures should be followed to prevent potential risks associated with its use.

Check Digit Verification of cas no

The CAS Registry Mumber 58512-50-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,1 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 58512-50:
(7*5)+(6*8)+(5*5)+(4*1)+(3*2)+(2*5)+(1*0)=128
128 % 10 = 8
So 58512-50-8 is a valid CAS Registry Number.

58512-50-8Relevant articles and documents

Hyperconjugation and the increasing bulk of OCOCX3 substituents in trans-1,4-disubstituted cyclohexanes destabilize the diequatorial conformer

Kleinpeter, Erich,Rolla, Nadja,Koch, Andreas,Taddei, Ferdinando

, p. 4393 - 4399 (2006)

The trans diesters of 1,4-cyclohexanediol with a number of acetic acid analogues, CX3COOH, of varying steric hindrance and polarity (CX 3 = Me, Et, iso-Pr, tert-Bu, CF3, CH2Cl, CHCl2, CCl3,

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

-

Page/Page column 362; 363, (2018/03/25)

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

Novel electrochemical deoxygenation reaction using diphenylphosphinates

Lam, Kevin,Marko, Istvan E.

supporting information; experimental part, p. 406 - 409 (2011/04/18)

The electrochemical reduction of diphenylphosphinate esters leads smoothly and in high yields to the corresponding deoxygenated products. In comparison with the previously developed methodologies, the electrolysis could be performed at lower temperature and with a higher current density, resulting in a shorter reaction time.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58512-50-8